BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8348848)

  • 21. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer.
    Suthananthan AE; Bhandari M; Platell C
    ANZ J Surg; 2018 May; 88(5):445-449. PubMed ID: 28512795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of oncologic follow-up of patients operated for colorectal cancer. A prospective study of 1000 patients].
    Arnaud JP; Cervi C; Bergamaschi R; Tuech JJ
    J Chir (Paris); 1997 Jul; 134(2):45-50. PubMed ID: 9378783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of follow-up programs in patients previously resected for colorectal cancer.
    Pugliese V; Aste H; Saccomanno S; Bruzzi P; Bonelli L; Santi L
    Tumori; 1984 Apr; 70(2):203-8. PubMed ID: 6730019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery.
    Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U
    Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the use of several instrumental methods in the follow-up of colorectal cancer. Preliminary results].
    Tropea A; Ranzato R; Erroi F; Frego M; D'Amico D
    Minerva Med; 1984 Sep; 75(36):2037-40. PubMed ID: 6384825
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of a follow-up programme after curative resection for colorectal cancer.
    Howell JD; Wotherspoon H; Leen E; Cooke TC; McArdle CS
    Br J Cancer; 1999 Jan; 79(2):308-10. PubMed ID: 9888473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer.
    Wanebo JH; Stearns M; Schwartz MK
    Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas.
    Mackay AM; Patel S; Carter S; Stevens U; Laurence DJ; Cooper EH; Neville AM
    Br Med J; 1974 Nov; 4(5941):382-5. PubMed ID: 4425888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Is it necessary to monitor patients surgically treated for colorectal cancer?].
    Millat B; Borie F
    J Chir (Paris); 1998 Oct; 135(4):177-81. PubMed ID: 9827400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of recurrent colorectal cancers].
    Schildberg FW; Lange V; Thies E; Meyer G
    Chirurg; 1985 Aug; 56(8):509-14. PubMed ID: 4042768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endoscopic monitoring after excision of colorectal cancer].
    Faivre J
    J Chir (Paris); 1997 Dec; 134(7-8):283-5. PubMed ID: 9772990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study.
    Pietra N; Sarli L; Costi R; Ouchemi C; Grattarola M; Peracchia A
    Dis Colon Rectum; 1998 Sep; 41(9):1127-33. PubMed ID: 9749496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [What does after care in colorectal cancer accomplish? A prospective study over an 8-year period].
    Schiessel R; Wenzl E
    Wien Med Wochenschr; 1988 Jun; 138(11-12):263-6. PubMed ID: 2459856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Resection of combined or sequential lung and liver metastases of colorectal cancer: indication for everyone?].
    Imdahl A; Fischer E; Tenckhof C; Hasse J; Hopt UT; Stoelben E
    Zentralbl Chir; 2005 Dec; 130(6):539-43. PubMed ID: 16382401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Individual risk-related after-care in colorectal cancer?].
    Böhm B; Osswald J; Hucke HP; Stock W
    Langenbecks Arch Chir; 1991; 376(6):314-22. PubMed ID: 1723133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical treatment of hepatic and pulmonary metastases from colorectal cancers.
    Regnard JF; Grunenwald D; Spaggiari L; Girard P; Elias D; Ducreux M; Baldeyrou P; Levasseur P
    Ann Thorac Surg; 1998 Jul; 66(1):214-8; discussion 218-9. PubMed ID: 9692467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of relapse and outcome after curative resection for colorectal cancer: a Japanese multicenter study.
    Kobayashi H; Mochizuki H; Morita T; Kotake K; Teramoto T; Kameoka S; Saito Y; Takahashi K; Hase K; Ohya M; Maeda K; Hirai T; Kameyama M; Shirouzu K; Sugihara K;
    Dig Surg; 2009; 26(3):249-55. PubMed ID: 19571539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second-look surgery for recurrent colorectal carcinoma: is it worthwhile?
    Bleday R; Steele G
    Semin Surg Oncol; 1991; 7(3):171-6. PubMed ID: 2068452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of follow-up programs in the reduction of mortality of rectal cancer recurrences.
    Komborozos VA; Skrekas GJ; Pissiotis CA
    Dig Surg; 2001; 18(5):403-8. PubMed ID: 11721117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary resection for metastatic colon and upper rectum cancer. Is it useful?
    Scheele J; Altendorf-Hofmann A; Stangl R; Gall FP
    Dis Colon Rectum; 1990 Sep; 33(9):745-52. PubMed ID: 2390909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.